Functional expression of a novel Kunitz type protease inhibitor from the human blood fluke Schistosoma mansoni
Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this ex...
Saved in:
| Published in | Parasites & vectors Vol. 8; no. 1; p. 408 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
04.08.2015
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1756-3305 1756-3305 |
| DOI | 10.1186/s13071-015-1022-z |
Cover
| Abstract | Background
Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths.
Methods
We have cloned one gene sequence from
S. mansoni
, Smp_147730 (
SmKI-1
) which is coded for single domain Kunitz type protease inhibitor,
E. coli
-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1.
Results
SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC
50
values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time.
Conclusions
We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from
S. mansoni
and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. |
|---|---|
| AbstractList | Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC.sub.50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 [mu]M) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Abstract Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. Methods We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. Results SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. Conclusions We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. BACKGROUND: Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. METHODS: We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. RESULTS: SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC₅₀ values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. CONCLUSIONS: We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. Methods We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. Results SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. Conclusions We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. Methods We have cloned one gene sequence from S. mansoni , Smp_147730 ( SmKI-1 ) which is coded for single domain Kunitz type protease inhibitor, E. coli -expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. Results SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC 50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. Conclusions We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths.BACKGROUNDSchistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths.We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1.METHODSWe have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1.SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time.RESULTSSmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 μM) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time.We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control.CONCLUSIONSWe have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host immune system. Protease inhibitors likely play a critical role in host immune modulation thereby promoting parasite survival in this extremely hostile environment. Even though Kunitz type serine protease inhibitors have been shown to play important physiological functions in a range of organisms these proteins are less well characterised in parasitic helminths. Methods We have cloned one gene sequence from S. mansoni, Smp_147730 (SmKI-1) which is coded for single domain Kunitz type protease inhibitor, E. coli-expressed and purified. Immunolocalisation and western blotting was carried out using affinity purified polyclonal anti-SmKI-1 murine antibodies to determine SmKI-1 expression in the parasite. Protease inhibitor assays and coagulation assays were performed to evaluate the functional roles of SmKI-1. Results SmKI-1 is localised in the tegument of adult worms and the sub-shell region of eggs. Furthermore, this Kunitz protein is secreted into the host in the ES products of the adult worm. Recombinant SmKI-1 inhibited mammalian trypsin, chymotrypsin, neutrophil elastase, FXa and plasma kallikrein with IC.sub.50 values of 35 nM, 61 nM, 56 nM, 142 nM and 112 nM, respectively. However, no inhibition was detected for pancreatic elastase or cathepsin G. SmKI-1 (4 [mu]M) delayed blood clot formation, reflected in an approximately three fold increase in activated partial thromboplastin time and prothrombin time. Conclusions We have functionally characterised the first Kunitz type protease inhibitor (SmKI-1) from S. mansoni and show that it has anti-inflammatory and anti-coagulant properties. SmKI-1 is one of a number of putative Kunitz proteins in schistosomes that have presumably evolved as an adaptation to protect these parasites from the defence mechanisms of their mammalian hosts. As such they may represent novel vaccine candidates and/or drug targets for schistosomiasis control. Keywords: Kunitz type protease inhibitor, SmKI-1, Schistosoma mansoni, Anti-coagulant |
| ArticleNumber | 408 |
| Audience | Academic |
| Author | Gobert, Geoffrey N. McManus, Donald P. Ranasinghe, Shiwanthi L. Fischer, Katja |
| Author_xml | – sequence: 1 givenname: Shiwanthi L. surname: Ranasinghe fullname: Ranasinghe, Shiwanthi L. email: shiwanthi.ranasinghe@qimrberghofer.edu.au organization: Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, School of Public Health, The University of Queensland – sequence: 2 givenname: Katja surname: Fischer fullname: Fischer, Katja organization: Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute – sequence: 3 givenname: Geoffrey N. surname: Gobert fullname: Gobert, Geoffrey N. organization: Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute – sequence: 4 givenname: Donald P. surname: McManus fullname: McManus, Donald P. email: Don.McManus@qimrberghofer.edu.au organization: Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26238343$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhSNURNuBH8AGWWIDixS_4iQbpKqiUFEJicLacuybGQ-JPdhO1c6vx8OUMlPxkBdx7O8cX1-f4-LAeQdF8ZzgE0Ia8SYShmtSYlKVBFNarh8VR6SuRMkYrg525ofFcYxLjAVuK_GkOKSCsoZxdlS488npZL1TA4KbVYAY8w_yPVLI-WsY0MfJ2bRG6XYFaBV8AhUBWbewnU0-oD74EaUFoMU0Koe6wXuD-mH6BuhKL2xMPvpRobwXvbNPi8e9GiI8u_vOiq_n776cfSgvP72_ODu9LLWocSpbw3outKYtsJZRoxhAZ5jhjBMhhGoazpqq6TRpFNeqqgUxlLO21qauQBk2Ky62vsarpVwFO6pwK72y8ueCD3OpQrJ6AInBUNw2QLjpOO1pp0Q-g9RGtR2mps5eb7deq6kbwWhwKahhz3R_x9mFnPtrySvKaa50Vry6Mwj--wQxydFGDcOgHPgpSooxJvmZ8lX_h5Ia52IxqzZlvXyALv0U8jtuqAaLlmTP39Rc5bta1_tcot6YytMqNxNz2tJMnfyBysPAaHUOXW_z-p7g9Z4gMwlu0lxNMcqLq8_77Ivd_t037lcIM0C2gA4-xgD9PUKw3ARdboMuc9DlJuhynTX1A422SW2CnCu3wz-VdKuM-RQ3h7DTt7-KfgDfDRCF |
| CitedBy_id | crossref_primary_10_1016_j_ijid_2017_10_024 crossref_primary_10_1016_j_pt_2016_12_013 crossref_primary_10_1186_s13071_017_2095_7 crossref_primary_10_3390_biomedicines10071679 crossref_primary_10_3389_fcimb_2021_702125 crossref_primary_10_1074_jbc_M116_724344 crossref_primary_10_1016_j_fsi_2023_108738 crossref_primary_10_3389_fimmu_2019_02498 crossref_primary_10_1186_s12864_021_08219_4 crossref_primary_10_1038_s41597_023_02674_2 crossref_primary_10_1016_j_actatropica_2025_107566 crossref_primary_10_1016_j_fsi_2020_08_023 crossref_primary_10_3389_fimmu_2021_635513 crossref_primary_10_3389_fimmu_2023_1163364 crossref_primary_10_3390_vaccines9070762 crossref_primary_10_3389_fimmu_2018_01762 crossref_primary_10_7717_peerj_11208 crossref_primary_10_1371_journal_pntd_0004268 crossref_primary_10_1371_journal_pone_0159704 crossref_primary_10_1371_journal_ppat_1006169 crossref_primary_10_3390_toxins14030170 crossref_primary_10_1186_s13071_017_2585_7 crossref_primary_10_1007_s12639_025_01785_4 crossref_primary_10_3389_fimmu_2020_624178 crossref_primary_10_1016_j_exppara_2019_04_004 crossref_primary_10_1016_j_micinf_2018_01_003 crossref_primary_10_1371_journal_pntd_0009200 crossref_primary_10_3390_microorganisms12061164 crossref_primary_10_1016_j_ijpara_2018_11_010 crossref_primary_10_3390_ph13090215 crossref_primary_10_1111_pim_12916 crossref_primary_10_1039_D3CE00767G crossref_primary_10_1016_j_parepi_2020_e00176 crossref_primary_10_1007_s00239_020_09959_9 crossref_primary_10_1016_j_ijbiomac_2023_124649 crossref_primary_10_1186_s13071_016_1615_1 crossref_primary_10_1186_s12915_021_01189_9 crossref_primary_10_3389_fimmu_2021_619776 crossref_primary_10_7717_peerj_12606 crossref_primary_10_1016_j_ijpara_2021_05_002 crossref_primary_10_1051_parasite_2024067 crossref_primary_10_1371_journal_ppat_1006870 crossref_primary_10_1016_j_ijpara_2016_01_002 crossref_primary_10_1371_journal_pntd_0009007 crossref_primary_10_1016_j_immuni_2018_10_016 crossref_primary_10_1038_s41598_020_77687_7 crossref_primary_10_1016_j_molimm_2024_09_006 crossref_primary_10_1371_journal_pntd_0007743 |
| Cites_doi | 10.1016/j.molbiopara.2009.04.008 10.5483/BMBRep.2002.35.2.199 10.1016/S0140-6736(06)69440-3 10.1016/0003-2697(76)90527-3 10.1093/bjaceaccp/mkm002 10.1002/iub.186 10.1016/j.ibmb.2012.09.005 10.1371/journal.pntd.0002091 10.1016/0014-4894(88)90014-8 10.1038/nrg3185 10.1006/expr.1994.1013 10.1038/nmeth.1701 10.1006/jmbi.1999.2757 10.1016/j.dci.2012.10.005 10.1016/0166-6851(95)02478-6 10.1074/mcp.M800538-MCP200 10.1017/S0031182000086017 10.1371/journal.pone.0027548 10.1371/journal.pntd.0002467 10.1186/1678-9199-19-3 10.1371/journal.pntd.0001009 10.1093/nar/gkn180 10.1038/msb.2011.75 10.1017/S0031182000047545 10.1645/0022-3395(2003)089[0402:MCOANM]2.0.CO;2 10.1016/S1471-4906(00)01803-2 10.1645/GE-96R 10.1084/jem.20091903 10.1016/j.jprot.2011.06.011 10.1371/journal.pone.0029964 10.1007/s00018-005-5578-1 10.1017/S0031182097001091 10.1085/jgp.19.6.991 10.1182/blood.V49.4.619.619 10.1038/nri1785 10.1084/jem.20122220 10.1128/IAI.72.4.2214-2221.2004 10.1371/journal.pone.0053343 10.1038/nm0810-851 10.1074/mcp.M112.019844 10.1016/S1471-4922(01)01891-8 10.1016/S0006-291X(67)80055-X 10.1093/nar/gks1067 10.1016/j.peptides.2011.09.022 10.1590/S0001-37652011000200025 10.1007/978-1-62703-339-8_10 10.1371/journal.pntd.0000262 10.1186/gb-2003-4-9-117 10.1016/j.ijpara.2006.01.007 10.1371/journal.ppat.1003781 10.1146/annurev.bi.49.070180.003113 10.1371/journal.pone.0007009 10.1016/j.molbiopara.2008.11.005 10.1371/journal.pntd.0000600 10.1093/abbs/gmp089 |
| ContentType | Journal Article |
| Copyright | Ranasinghe et al. 2015 COPYRIGHT 2015 BioMed Central Ltd. Copyright BioMed Central 2015 |
| Copyright_xml | – notice: Ranasinghe et al. 2015 – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Copyright BioMed Central 2015 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7SN 7SS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO F1W FYUFA GHDGH H95 K9. L.G M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1186/s13071-015-1022-z |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Ecology Abstracts Entomology Abstracts (Full archive) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea ASFA: Aquatic Sciences and Fisheries Abstracts Health Research Premium Collection Health Research Premium Collection (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest Health & Medical Collection Medical Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Ecology Abstracts ProQuest Hospital Collection (Alumni) Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Zoology |
| EISSN | 1756-3305 |
| EndPage | 408 |
| ExternalDocumentID | oai_doaj_org_article_0ed2098e14db42f2ba616617da9b02d7 PMC4524284 4020710961 A541604292 26238343 10_1186_s13071_015_1022_z |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Australia Germany |
| GeographicLocations_xml | – name: Germany – name: Australia |
| GrantInformation_xml | – fundername: National Health and Medical Research Council funderid: http://dx.doi.org/10.13039/501100000925 – fundername: University of Queensland grantid: UQI funderid: http://dx.doi.org/10.13039/501100001794 |
| GroupedDBID | --- 0R~ 123 29O 2WC 2XV 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS ECGQY EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7SN 7SS 7XB 8FK AZQEC C1K DWQXO F1W H95 K9. L.G M7N PKEHL PQEST PQUKI PRINS 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c670t-9d3f46cc29e3932da3eebd3d4341666a8843858bc18a4ca5761d24397cd75ead3 |
| IEDL.DBID | M48 |
| ISSN | 1756-3305 |
| IngestDate | Wed Aug 27 01:33:25 EDT 2025 Thu Aug 21 14:00:41 EDT 2025 Thu Sep 04 16:21:28 EDT 2025 Fri Sep 05 02:56:30 EDT 2025 Sat Jul 26 02:24:32 EDT 2025 Tue Jun 17 22:05:07 EDT 2025 Tue Jun 10 21:04:49 EDT 2025 Fri Jun 27 05:59:02 EDT 2025 Thu Apr 03 06:59:09 EDT 2025 Thu Apr 24 23:01:38 EDT 2025 Tue Jul 01 02:43:47 EDT 2025 Sat Sep 06 07:28:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Kunitz type protease inhibitor SmKI-1 Anti-coagulant |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c670t-9d3f46cc29e3932da3eebd3d4341666a8843858bc18a4ca5761d24397cd75ead3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13071-015-1022-z |
| PMID | 26238343 |
| PQID | 1780691133 |
| PQPubID | 55241 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0ed2098e14db42f2ba616617da9b02d7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4524284 proquest_miscellaneous_2000133039 proquest_miscellaneous_1702090357 proquest_journals_1780691133 gale_infotracmisc_A541604292 gale_infotracacademiconefile_A541604292 gale_incontextgauss_ISR_A541604292 pubmed_primary_26238343 crossref_primary_10_1186_s13071_015_1022_z crossref_citationtrail_10_1186_s13071_015_1022_z springer_journals_10_1186_s13071_015_1022_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-08-04 |
| PublicationDateYYYYMMDD | 2015-08-04 |
| PublicationDate_xml | – month: 08 year: 2015 text: 2015-08-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Parasites & vectors |
| PublicationTitleAbbrev | Parasites Vectors |
| PublicationTitleAlternate | Parasit Vectors |
| PublicationYear | 2015 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | F Liu (1022_CR24) 2009; 8 S Ranasinghe (1022_CR17) 2013; 39 A Freudenstein-Dan (1022_CR4) 2003; 89 A Dereeper (1022_CR28) 2008; 36 AR Sousa de (1022_CR50) 2009; 5 WK Jung (1022_CR33) 2002; 35 SE Bozas (1022_CR18) 1995; 74 D Krowarsch (1022_CR16) 1999; 289 R Zhao (1022_CR11) 2011; 6 MP Isaeva (1022_CR9) 2012; 34 LA Quezada (1022_CR6) 2011; 83 E Hansell (1022_CR51) 2008; 2 MM Mebius (1022_CR43) 2013; 9 MW Lightowlers (1022_CR45) 1988; 96 Suppl XJ Wu (1022_CR52) 2009; 164 VC Tsang (1022_CR2) 1977; 49 MM Bradford (1022_CR29) 1976; 72 AN Curry (1022_CR34) 2007; 7 JM Hawdon (1022_CR19) 2003; 89 M Chai (1022_CR57) 2006; 63 AGM Abdel Gader (1022_CR59) 2009; 4 MA Alim (1022_CR7) 2012; 42 D Chu (1022_CR8) 2004; 72 JJ Collins 3rd (1022_CR31) 2011; 5 W Ruf (1022_CR42) 2010; 16 L Zhu (1022_CR12) 2009; 41 M Laskowski Jr (1022_CR14) 1980; 49 LH Brink (1022_CR22) 1977; 74 JP Dalton (1022_CR23) 1997; 115 CJ Sigrist (1022_CR26) 2013; 41 W Castro-Borges (1022_CR53) 2011; 74 D Greenbaum (1022_CR49) 2003; 4 H Salmanizadeh (1022_CR35) 2013; 19 T Wang (1022_CR48) 2013; 7 H Wan (1022_CR10) 2013; 8 M Kunitz (1022_CR13) 1936; 19 B Gryseels (1022_CR1) 2006; 368 GN Gobert (1022_CR30) 2010; 4 JP Hewitson (1022_CR46) 2009; 167 I Schechter (1022_CR15) 1967; 27 F Sievers (1022_CR27) 2011; 7 Y Ghendler (1022_CR5) 1994; 78 1022_CR32 BC Mourik (1022_CR44) 2010; 1 PB Armstrong (1022_CR38) 2001; 22 C Nathan (1022_CR40) 2006; 6 V Ignjatovic (1022_CR36) 2013; 992 H Tsujimoto (1022_CR37) 2012; 7 A Mócsai (1022_CR41) 2013; 210 S Gonzalez (1022_CR20) 2009; 4 TN Petersen (1022_CR25) 2011; 8 RC Andrew Thompson (1022_CR58) 2001; 17 JJ Hellemond Van (1022_CR54) 2006; 36 C Cantacessi (1022_CR47) 2012; 11 E Cera Di (1022_CR39) 2009; 61 AV Protasio (1022_CR21) 2013; 7 C Vogel (1022_CR55) 2012; 13 RM Maizels (1022_CR3) 2009; 206 B Salafsky (1022_CR56) 1988; 67 6035483 - Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62 23308198 - PLoS One. 2013;8(1):e53343 12760667 - J Parasitol. 2003 Apr;89(2):402-7 23186642 - Dev Comp Immunol. 2013 Mar;39(3):219-27 19759914 - PLoS One. 2009;4(9):e7009 19180666 - IUBMB Life. 2009 May;61(5):510-5 9226954 - Parasitology. 1997 Jul;115 ( Pt 1):29-32 24098821 - PLoS Negl Trop Dis. 2013;7(10):e2467 19095013 - Mol Biochem Parasitol. 2009 Mar;164(1):32-44 24385897 - PLoS Pathog. 2013;9(12):e1003781 21704203 - J Proteomics. 2011 Aug 24;74(9):1519-33 8719242 - Mol Biochem Parasitol. 1995 Oct;74(1):19-29 320543 - Parasitology. 1977 Feb;74(1):73-86 14740899 - J Parasitol. 2003 Dec;89(6):1129-35 23546710 - Methods Mol Biol. 2013;992:131-8 18629379 - PLoS Negl Trop Dis. 2008;2(7):e262 23017545 - Insect Biochem Mol Biol. 2012 Dec;42(12):925-34 19770272 - J Exp Med. 2009 Sep 28;206(10):2059-66 22383955 - PLoS One. 2012;7(2):e29964 11360886 - Trends Parasitol. 2001 Apr;17(4):168 16545817 - Int J Parasitol. 2006 May 31;36(6):691-9 21959131 - Nat Methods. 2011;8(10):785-6 20161728 - PLoS Negl Trop Dis. 2010;4(2):e600 23161676 - Nucleic Acids Res. 2013 Jan;41(Database issue):D344-7 20689544 - Nat Med. 2010 Aug;16(8):851-2 11286692 - Trends Immunol. 2001 Jan;22(1):47-52 3287288 - Parasitology. 1988;96 Suppl:S123-66 19406170 - Mol Biochem Parasitol. 2009 Sep;167(1):1-11 21670886 - An Acad Bras Cienc. 2011 Jun;83(2):663-72 22411467 - Nat Rev Genet. 2012 Apr;13(4):227-32 8119369 - Exp Parasitol. 1994 Mar;78(2):121-31 6996568 - Annu Rev Biochem. 1980;49:593-626 10339415 - J Mol Biol. 1999 May 28;289(1):175-86 19299421 - Mol Cell Proteomics. 2009 Jun;8(6):1236-51 23825232 - J Exp Med. 2013 Jul 1;210(7):1283-99 22087336 - PLoS One. 2011;6(11):e27548 22001835 - Peptides. 2012 Mar;34(1):88-97 16997665 - Lancet. 2006 Sep 23;368(9541):1106-18 942051 - Anal Biochem. 1976 May 7;72:248-54 843620 - Blood. 1977 Apr;49(4):619-33 20023718 - Mol Biosyst. 2009 Dec;5(12):1512-26 15039345 - Infect Immun. 2004 Apr;72(4):2214-21 16498448 - Nat Rev Immunol. 2006 Mar;6(3):173-82 23848979 - J Venom Anim Toxins Incl Trop Dis. 2013 Feb 27;19(1):3 12952525 - Genome Biol. 2003;4(9):117 23516644 - PLoS Negl Trop Dis. 2013;7(3):e2091 22899770 - Mol Cell Proteomics. 2012 Nov;11(11):1340-53 19902129 - Acta Biochim Biophys Sin (Shanghai). 2009 Nov;41(11):948-54 12297030 - J Biochem Mol Biol. 2002 Mar 31;35(2):199-205 21988835 - Mol Syst Biol. 2011;7:539 2458958 - Exp Parasitol. 1988 Oct;67(1):116-27 16570121 - Cell Mol Life Sci. 2006 Apr;63(7-8):919-29 21408085 - PLoS Negl Trop Dis. 2011;5(3):e1009 19872978 - J Gen Physiol. 1936 Jul 20;19(6):991-1007 18424797 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W465-9 |
| References_xml | – volume: 167 start-page: 1 issue: 1 year: 2009 ident: 1022_CR46 publication-title: Mol Biochem Parasit doi: 10.1016/j.molbiopara.2009.04.008 – volume: 5 start-page: 1512 issue: 12 year: 2009 ident: 1022_CR50 publication-title: Mol Biosyst – volume: 35 start-page: 199 issue: 2 year: 2002 ident: 1022_CR33 publication-title: J Biochem Mol Biol doi: 10.5483/BMBRep.2002.35.2.199 – volume: 368 start-page: 1106 issue: 9541 year: 2006 ident: 1022_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(06)69440-3 – volume: 72 start-page: 248 year: 1976 ident: 1022_CR29 publication-title: Anal Biochem doi: 10.1016/0003-2697(76)90527-3 – volume: 7 start-page: 45 issue: 2 year: 2007 ident: 1022_CR34 publication-title: Cont Educ Anaesth Crit Care Pain doi: 10.1093/bjaceaccp/mkm002 – volume: 61 start-page: 510 issue: 5 year: 2009 ident: 1022_CR39 publication-title: IUBMB life doi: 10.1002/iub.186 – volume: 4 start-page: 1 issue: 1 year: 2009 ident: 1022_CR59 publication-title: J Taibah Univ Med Sci – volume: 42 start-page: 925 issue: 12 year: 2012 ident: 1022_CR7 publication-title: Insect Biochem Mol Biol doi: 10.1016/j.ibmb.2012.09.005 – volume: 7 start-page: e2091 issue: 3 year: 2013 ident: 1022_CR21 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002091 – volume: 1 start-page: 51 issue: 1 year: 2010 ident: 1022_CR44 publication-title: Erasmus J Med – volume: 67 start-page: 116 issue: 1 year: 1988 ident: 1022_CR56 publication-title: Exp Parasitol doi: 10.1016/0014-4894(88)90014-8 – volume: 13 start-page: 227 issue: 4 year: 2012 ident: 1022_CR55 publication-title: Nature Rev Genet doi: 10.1038/nrg3185 – volume: 78 start-page: 121 issue: 2 year: 1994 ident: 1022_CR5 publication-title: Exp Parasitol doi: 10.1006/expr.1994.1013 – volume: 8 start-page: 785 issue: 10 year: 2011 ident: 1022_CR25 publication-title: Nat Methods doi: 10.1038/nmeth.1701 – volume: 289 start-page: 175 issue: 1 year: 1999 ident: 1022_CR16 publication-title: J Mol Biol doi: 10.1006/jmbi.1999.2757 – volume: 39 start-page: 219 issue: 3 year: 2013 ident: 1022_CR17 publication-title: Dev Comp Immunol doi: 10.1016/j.dci.2012.10.005 – volume: 74 start-page: 19 issue: 1 year: 1995 ident: 1022_CR18 publication-title: Mol Biochem Parasitol doi: 10.1016/0166-6851(95)02478-6 – volume: 8 start-page: 1236 issue: 6 year: 2009 ident: 1022_CR24 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M800538-MCP200 – volume: 96 Suppl start-page: S123 issue: S1 year: 1988 ident: 1022_CR45 publication-title: Parasitology doi: 10.1017/S0031182000086017 – volume: 6 start-page: e27548 issue: 11 year: 2011 ident: 1022_CR11 publication-title: PLoS One doi: 10.1371/journal.pone.0027548 – volume: 7 start-page: e2467 issue: 10 year: 2013 ident: 1022_CR48 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002467 – volume: 19 start-page: 3 issue: 1 year: 2013 ident: 1022_CR35 publication-title: J Venom Anim Toxins Incl Trop Dis doi: 10.1186/1678-9199-19-3 – volume: 5 start-page: e1009 issue: 3 year: 2011 ident: 1022_CR31 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0001009 – volume: 36 start-page: W465 issue: Web Server issu year: 2008 ident: 1022_CR28 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkn180 – volume: 7 start-page: 539 year: 2011 ident: 1022_CR27 publication-title: Mol Syst Biol doi: 10.1038/msb.2011.75 – volume: 74 start-page: 73 issue: 1 year: 1977 ident: 1022_CR22 publication-title: Parasitology doi: 10.1017/S0031182000047545 – volume: 89 start-page: 402 issue: 2 year: 2003 ident: 1022_CR19 publication-title: J parasitol doi: 10.1645/0022-3395(2003)089[0402:MCOANM]2.0.CO;2 – volume: 22 start-page: 47 issue: 1 year: 2001 ident: 1022_CR38 publication-title: Trends Immunol doi: 10.1016/S1471-4906(00)01803-2 – volume: 89 start-page: 1129 issue: 6 year: 2003 ident: 1022_CR4 publication-title: J Parasitol doi: 10.1645/GE-96R – volume: 206 start-page: 2059 issue: 10 year: 2009 ident: 1022_CR3 publication-title: J Exp Med doi: 10.1084/jem.20091903 – ident: 1022_CR32 – volume: 74 start-page: 1519 issue: 9 year: 2011 ident: 1022_CR53 publication-title: J Proteomics doi: 10.1016/j.jprot.2011.06.011 – volume: 7 start-page: e29964 issue: 2 year: 2012 ident: 1022_CR37 publication-title: PloS One doi: 10.1371/journal.pone.0029964 – volume: 63 start-page: 919 issue: 7–8 year: 2006 ident: 1022_CR57 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-005-5578-1 – volume: 115 start-page: 29 issue: Pt 1 year: 1997 ident: 1022_CR23 publication-title: Parasitology doi: 10.1017/S0031182097001091 – volume: 19 start-page: 991 issue: 6 year: 1936 ident: 1022_CR13 publication-title: J Gen Physiol doi: 10.1085/jgp.19.6.991 – volume: 49 start-page: 619 issue: 4 year: 1977 ident: 1022_CR2 publication-title: Blood doi: 10.1182/blood.V49.4.619.619 – volume: 6 start-page: 173 issue: 3 year: 2006 ident: 1022_CR40 publication-title: Nat Rev Immunol doi: 10.1038/nri1785 – volume: 210 start-page: 1283 issue: 7 year: 2013 ident: 1022_CR41 publication-title: J Exp Med doi: 10.1084/jem.20122220 – volume: 72 start-page: 2214 issue: 4 year: 2004 ident: 1022_CR8 publication-title: Infect Immun doi: 10.1128/IAI.72.4.2214-2221.2004 – volume: 8 start-page: e53343 issue: 1 year: 2013 ident: 1022_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0053343 – volume: 16 start-page: 851 issue: 8 year: 2010 ident: 1022_CR42 publication-title: Nat Med doi: 10.1038/nm0810-851 – volume: 11 start-page: 1340 issue: 11 year: 2012 ident: 1022_CR47 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M112.019844 – volume: 17 start-page: 168 issue: 4 year: 2001 ident: 1022_CR58 publication-title: Trends Parasitol doi: 10.1016/S1471-4922(01)01891-8 – volume: 27 start-page: 157 issue: 2 year: 1967 ident: 1022_CR15 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(67)80055-X – volume: 41 start-page: D344 issue: Database issue year: 2013 ident: 1022_CR26 publication-title: Nucleic Acids Res doi: 10.1093/nar/gks1067 – volume: 34 start-page: 88 issue: 1 year: 2012 ident: 1022_CR9 publication-title: Peptides doi: 10.1016/j.peptides.2011.09.022 – volume: 83 start-page: 663 issue: 2 year: 2011 ident: 1022_CR6 publication-title: An Acad Bras Cienc doi: 10.1590/S0001-37652011000200025 – volume: 992 start-page: 131 year: 2013 ident: 1022_CR36 publication-title: Methods Mol Biol doi: 10.1007/978-1-62703-339-8_10 – volume: 2 start-page: e262 issue: 7 year: 2008 ident: 1022_CR51 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0000262 – volume: 4 start-page: 117 issue: 9 year: 2003 ident: 1022_CR49 publication-title: Genome Biol doi: 10.1186/gb-2003-4-9-117 – volume: 36 start-page: 691 issue: 6 year: 2006 ident: 1022_CR54 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2006.01.007 – volume: 9 start-page: e1003781 issue: 12 year: 2013 ident: 1022_CR43 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003781 – volume: 49 start-page: 593 year: 1980 ident: 1022_CR14 publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.49.070180.003113 – volume: 4 start-page: e7009 issue: 9 year: 2009 ident: 1022_CR20 publication-title: PloS one doi: 10.1371/journal.pone.0007009 – volume: 164 start-page: 32 issue: 1 year: 2009 ident: 1022_CR52 publication-title: Mol Biochem Parasitol doi: 10.1016/j.molbiopara.2008.11.005 – volume: 4 start-page: e600 issue: 2 year: 2010 ident: 1022_CR30 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0000600 – volume: 41 start-page: 948 issue: 11 year: 2009 ident: 1022_CR12 publication-title: Acta Biochim Biophys Sin (Shanghai) doi: 10.1093/abbs/gmp089 – reference: 18629379 - PLoS Negl Trop Dis. 2008;2(7):e262 – reference: 16498448 - Nat Rev Immunol. 2006 Mar;6(3):173-82 – reference: 23017545 - Insect Biochem Mol Biol. 2012 Dec;42(12):925-34 – reference: 23308198 - PLoS One. 2013;8(1):e53343 – reference: 14740899 - J Parasitol. 2003 Dec;89(6):1129-35 – reference: 21670886 - An Acad Bras Cienc. 2011 Jun;83(2):663-72 – reference: 23161676 - Nucleic Acids Res. 2013 Jan;41(Database issue):D344-7 – reference: 21959131 - Nat Methods. 2011;8(10):785-6 – reference: 19406170 - Mol Biochem Parasitol. 2009 Sep;167(1):1-11 – reference: 2458958 - Exp Parasitol. 1988 Oct;67(1):116-27 – reference: 24098821 - PLoS Negl Trop Dis. 2013;7(10):e2467 – reference: 12297030 - J Biochem Mol Biol. 2002 Mar 31;35(2):199-205 – reference: 22001835 - Peptides. 2012 Mar;34(1):88-97 – reference: 20161728 - PLoS Negl Trop Dis. 2010;4(2):e600 – reference: 21408085 - PLoS Negl Trop Dis. 2011;5(3):e1009 – reference: 11360886 - Trends Parasitol. 2001 Apr;17(4):168 – reference: 19759914 - PLoS One. 2009;4(9):e7009 – reference: 19299421 - Mol Cell Proteomics. 2009 Jun;8(6):1236-51 – reference: 23186642 - Dev Comp Immunol. 2013 Mar;39(3):219-27 – reference: 21988835 - Mol Syst Biol. 2011;7:539 – reference: 20023718 - Mol Biosyst. 2009 Dec;5(12):1512-26 – reference: 320543 - Parasitology. 1977 Feb;74(1):73-86 – reference: 16545817 - Int J Parasitol. 2006 May 31;36(6):691-9 – reference: 12952525 - Genome Biol. 2003;4(9):117 – reference: 6035483 - Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62 – reference: 22899770 - Mol Cell Proteomics. 2012 Nov;11(11):1340-53 – reference: 16570121 - Cell Mol Life Sci. 2006 Apr;63(7-8):919-29 – reference: 21704203 - J Proteomics. 2011 Aug 24;74(9):1519-33 – reference: 20689544 - Nat Med. 2010 Aug;16(8):851-2 – reference: 19872978 - J Gen Physiol. 1936 Jul 20;19(6):991-1007 – reference: 8119369 - Exp Parasitol. 1994 Mar;78(2):121-31 – reference: 3287288 - Parasitology. 1988;96 Suppl:S123-66 – reference: 23546710 - Methods Mol Biol. 2013;992:131-8 – reference: 23848979 - J Venom Anim Toxins Incl Trop Dis. 2013 Feb 27;19(1):3 – reference: 19180666 - IUBMB Life. 2009 May;61(5):510-5 – reference: 15039345 - Infect Immun. 2004 Apr;72(4):2214-21 – reference: 22383955 - PLoS One. 2012;7(2):e29964 – reference: 22087336 - PLoS One. 2011;6(11):e27548 – reference: 18424797 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W465-9 – reference: 843620 - Blood. 1977 Apr;49(4):619-33 – reference: 19902129 - Acta Biochim Biophys Sin (Shanghai). 2009 Nov;41(11):948-54 – reference: 23825232 - J Exp Med. 2013 Jul 1;210(7):1283-99 – reference: 942051 - Anal Biochem. 1976 May 7;72:248-54 – reference: 8719242 - Mol Biochem Parasitol. 1995 Oct;74(1):19-29 – reference: 9226954 - Parasitology. 1997 Jul;115 ( Pt 1):29-32 – reference: 11286692 - Trends Immunol. 2001 Jan;22(1):47-52 – reference: 24385897 - PLoS Pathog. 2013;9(12):e1003781 – reference: 23516644 - PLoS Negl Trop Dis. 2013;7(3):e2091 – reference: 19770272 - J Exp Med. 2009 Sep 28;206(10):2059-66 – reference: 22411467 - Nat Rev Genet. 2012 Apr;13(4):227-32 – reference: 19095013 - Mol Biochem Parasitol. 2009 Mar;164(1):32-44 – reference: 12760667 - J Parasitol. 2003 Apr;89(2):402-7 – reference: 6996568 - Annu Rev Biochem. 1980;49:593-626 – reference: 10339415 - J Mol Biol. 1999 May 28;289(1):175-86 – reference: 16997665 - Lancet. 2006 Sep 23;368(9541):1106-18 |
| SSID | ssj0060956 |
| Score | 2.300253 |
| Snippet | Background
Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the... Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the host... Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of the... BACKGROUND: Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and mediators of... Abstract Background Schistosomes are able to survive for prolonged periods in the blood system, despite continuous contact with coagulatory factors and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 408 |
| SubjectTerms | adults Amino Acid Sequence Animals Anti-coagulant Antibodies anticoagulants Biomedical and Life Sciences Biomedicine Blood blood coagulation Blood coagulation factors blood flukes cathepsins chymotrypsin Cloning, Molecular coagulation defense mechanisms DNA, Helminth eggs elastase Entomology Enzymes Escherichia coli Gene Expression Regulation - physiology Genetic aspects Helminth Proteins - genetics Helminth Proteins - metabolism hosts humans Hydrolases Infectious Diseases inhibitory concentration 50 Kunitz type protease inhibitor Medical examination mice Molecular Sequence Data neutrophils nucleotide sequences Parasitology Phylogeny Physiological aspects plasma kallikrein Protease inhibitors Protease Inhibitors - metabolism protein secretion proteinase inhibitors Proteins prothrombin Schistosoma mansoni Schistosoma mansoni - metabolism schistosomiasis SmKI-1 thromboplastin Tropical Medicine trypsin vaccines Veterinary Medicine/Veterinary Science Viral antibodies Virology Western blotting |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yIPgifls9JYogKMuladqkj6e4nIo-eB4cvoQ0H97imsp1K7J_vTNpd9menL74upnS7nxkfpNMfiHkmTDMFN7j7WV4JAdy9EzZvJkBmPBVCKWUBtc7Pnysjk7Eu9PydOeqL-wJG-iBB8UdMO84q5XPhWsED7wxVQ45RTpTN4y7dI6c1WxTTA1zMLKoVeMeZq6qgw5maollM7JuQvW1nmShRNb_55S8k5Mu9kte2DRNuWh-g1wfQSQ9HD7-Jrni4y1y9UublshvkziHZDWs8VH_a-x0jbQN1NDY_vRL-r6HSF5TXH-liakBchldxLNFAwF-TvHMCQVkSNMNfjQ1t9Ow7L95emwTQ3HXfjcUxgCtL-6Qk_mbz6-PZuO9CjNbSbaa1a4IAvula18AfHNorMYVTkBGg2rGKCVwu7CxuTLCGqhIcscRuFgnS_C84i7Zi2309wkNNljDLZTRENcslKYJgLikqINhZRB5RthGz9qOpON498VSp-JDVXowjQbTaDSNXmfkxfaRHwPjxt-EX6HxtoJIlp1-ABfSowvpf7lQRp6i6TXSYUTst_lq-q7Tb48_6cMSVII5m2fk-SgUWvgH1ozHF0APyKA1kdyfSEK82unwxsP0OF90OpeKVZB3iiIjT7bD-CT2wEXf9ijD0NOLUl4uwxOmB1hSZ-Te4LRb3XBAuqoQ8AY5ceeJ8qYjcXGWGMdFCUhOiYy83Dj-zqdfZpsH_8M2D8k1jmGLTTpin-ytznv_CGDgqnmcIv43NaRY6Q priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gCIkXxDeFgQJCQgJVS9u0aZ_QQJwGCB4Yk068RGk-thNHO65XhO6vx05zZR3aXhtXbWI7_tlxbEJecMVUZi12L8MrOWCj41IndQxgwhbO5UIojHd8_lIcHPGP83weAm5dSKvc7ol-ozatxhj5XiJKVoBmZtmb018xdo3C09XQQuMquZYAEsHWDWI-OlxYS60IJ5lJWex1sF8LdJ6x9ib4YJuJLfIl-__fmM9YpvNZk-eOTr1Fmt0iNwOUpPsD72-TK7a5Q65_b32g_C5pZmCyhkgftX9CvmtDW0cVbdrfdkk_9aDPG4pRWOrrNYBFo4vmZFGDmq8o3jyhgA-p7-NHfYo7dcv-h6WH2tcp7tqfisIYYPbFPXI0e__t3UEcuivEuhBsHVcmcxyzpiubAYgzyLLaZIaDXQOfRpUlx0PDWiel4lqBX5KYFOGLNiIH-cvuk52mbexDQp12WqUanGnQbuZyVTvAXYJXTrHc8SQibLvOUofS49gBYym9C1IWcmCNBNZIZI3cROTV-MrpUHfjMuK3yLyREEtm-wft6lgGDZTMmpRVpU24qXnq0loVMM9EGFXVLDUiIs-R9RKLYjSYdXOs-q6THw6_yv0clgQtdxqRl4HItTADrcIlBlgHrKM1odydUILW6unwVsJk2DU6-U_GI_JsHMY3MROusW2PNADwK5bl4mKa1CN7ACdVRB4MQjuuTQp4t8w4fEFMxHmyeNORZnHi647zHPBcySPyeiv4Z379It48unyij8mNFBUSk3D4LtlZr3r7BGDeun7qdfkvcKxQXw priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fi9QwEA56Ivgi_rZ6ShRBUIppmjbt47m4nIo-eB4cvoQ0TbzFNZXrVmT_emfS7LI9PcHXZkLbzEzmm2TyhZBnQjOdW4u3l-GRHIjRaWWyJgUwYUvnCik1rnd8-FgeHot3J8VJJIvGszC7-_dZVb7qYY6VmPAiXybkTevL5EoBz9CYZ-VsM-kibVoZNy3_2m0SdgI7_59z8E4QOl8geW6XNASf-Q1yPaJGejCq-Sa5ZP0tcvVLF9bEbxM_h-g0LupR-yuWtnraOaqp737aJX0_gOuuKS640kDNAMGLLvzpogGPPqN4yIQCFKThyj4aqtmpWw7fLD0ygZK4775rCm0Azxd3yPH8zefZYRovUkhNKdkqrdvcCSyQrm0OeK1F7TRt3goIYZC-6KoSuD_YmKzSwmhIQbKWI1IxrSzA1PK7ZM933t4n1BlnNDeQN4MjM1foxgHEkqJ2mhVOZAlhm3FWJrKM42UXSxWyjapUo2oUqEahatQ6IS-2XX6MFBv_En6NytsKIjt2eABGo6KzKWZbzurKZqJtBHe80SX8ZyZbXTeMtzIhT1H1CvkvPBbYfNVD36u3R5_UQQFDgkGaJ-R5FHId_IHR8bwCjANSZk0k9yeS4KBm2ryxMBUniF5lsmIlBJo8T8iTbTP2xKI3b7sBZQDL1ywv5MUyPIB4wCF1Qu6NRrsdGw7QtsoFvEFOzHkyeNMWvzgNFOOiAOhWiYS83Bj-zqdfpJsH_yX9kFzj6J9YfiP2yd7qbLCPAOCtmsfBtX8DgiRJSA priority: 102 providerName: Springer Nature |
| Title | Functional expression of a novel Kunitz type protease inhibitor from the human blood fluke Schistosoma mansoni |
| URI | https://link.springer.com/article/10.1186/s13071-015-1022-z https://www.ncbi.nlm.nih.gov/pubmed/26238343 https://www.proquest.com/docview/1780691133 https://www.proquest.com/docview/1702090357 https://www.proquest.com/docview/2000133039 https://pubmed.ncbi.nlm.nih.gov/PMC4524284 https://doaj.org/article/0ed2098e14db42f2ba616617da9b02d7 |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3rb9MwED_tISS-IN5kjMogJCRQIQ8nTj4g1FWrRhETWqlU8cVyHHur6BLoA43-9dy5abWMjU98qhSfleYevt_Z5zuAl1z5KjKGupfRlRz00e1UB3kbwYRJrI2FULTf8fk4ORry_igebcG6vVXNwNm1oR31kxpOJ28vfv7-gAb_3hl8mryb4TosKCimmpoYWy23YdcdF1EmH98cKlBptaQ-2Lx2WsM1uQr-f6_TlxzV1STKKyepzkH17sKdGlmyzkoV7sGWKe_DrW-V2zd_AGUPPdhq44-Zizr9tWSVZYqV1S8zYZ8WaN5LRpuyzJVvQAfHxuXZOEernzK6iMIQLjLX1o-5jHdmJ4vvhg20K1s8q84VwzGE8OOHMOwdfu0etetmC22dCH_ezorIckqizkyEmK4gCeZFVHB0cxjiqDTldIaY6yBVXCsMU4IiJDSjCxGjOkaPYKesSvMEmNVWq1BjbI3G7ttY5RZhmOCZVX5seeCBv-az1HUlcmqIMZEuIkkTuRKNRNFIEo1cevB6M-XHqgzHv4gPSHgbQqqg7R5U01NZG6T0TRH6WWoCXuQ8tGGuEvzOQBQqy_2wEB68INFLqpFRUhLOqVrMZvLj4ER2YmQJOfLQg1c1ka3wC7Sq7zQgH6isVoNyv0GJRqybw2sNk2sbkIFI_QSdURR58HwzTDMpMa401YJoEO9nfhSLm2lCB_QRq2QePF4p7YY3IcLfNOL4BtFQ5wbzmiPl-MyVIecxwruUe_BmrfiX_vpNstn7H7J5CrdDMlvK3OH7sDOfLswzxIbzvAXbYiRasNvp9Ad9_D04PP5ygk-7Sbfl9ltabk34A9FsZnQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2ggEEgJFDUxHHi5IBQeay6bNsDbaVVL8Zx7HbFkpR98NgfxW9kxkmWpqi99bqeZOOZ8cw39niGkOdcBSoyBruX4ZUc8NF-qsPcBzBhEmtjIRTud2zvJJv7_NMwHq6QP-1dGEyrbG2iM9RFpXGPfD0UaZDAyoyit8fffewahaerbQuNWi0G5vdPCNmmb_ofQL4vGOt93Hu_6TddBXydiGDmZ0VkOWYLZyYC8FLgp-ZFVHCw54DlVZpyPCzLdZgqrhXg8bBg6LZ1IWLgewTvvUQuczxihPUjhssAD2u3Jc3JaZgm61PwDwKDdaz1CTHfouP7XIuA_x3BCU94Okvz1FGt84C9G-R6A13pRq1rN8mKKW-RKweV25i_TcoeuMh6Z5GaX01-bUkrSxUtqx9mTAdzsB8Liru-1NWHAA9KR-XRKAezMqF404UCHqWubyB1KfXUjudfDd3Vri7ytPqmKIxBjDC6Q_YvhO93yWpZleY-oVZbrZiG4B2sSWBjlVvAeYJnVgWx5aFHgpbPUjelzrHjxli6kCdNZC0aCaKRKBq58Mir5SPHdZ2P84jfofCWhFii2_1QTQ5ls-JlYAoWZKkJeZFzZlmuEphnKAqV5QErhEeeoeglFuEoMcvnUM2nU9nf_Sw3YmAJIgXmkZcNka1gBlo1lyaAD1i3q0O51qEEK6G7w62GycZKTeW_NeWRp8thfBIz70pTzZEGAoosiGJxNg1zkQSAocwj92qlXfKGAb5OIw7_IDrq3GFed6QcHbk65zwG_Jhyj7xuFf_Ep58lmwfnT_QJubq5t70lt_o7g4fkGsPFiQlAfI2sziZz8wgg5ix_7NY1JV8u2pD8BXdpjSw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELagFYgXxE2ggEFISKCoOZzYeVyOVbuFCrFUqnixHB_tiiWpNrsI7a9nxklWTaFIvMZjJZnxeL6xx58JeclUpFJr8fYyPJIDMToUOi5DABM2dy7jXOF6x6fDfO-ITY6z4-6e06avdu-3JNszDcjSVC13z4xrXVzkuw3MvBzTYGTRhGxqfZVsi6woIPvaHo0m00k_GSOdWt5tZv614yAcedb-P-fmc8HpYuHkhd1TH5TGt8jNDk3SUWv-2-SKre6Qa99qv1Z-l1RjiFrtYh-1v7qS14rWjipa1T_tnB6swKXXFBdiqadsgKBGZ9XprARPX1A8fEIBIlJ_lR_1Ve7UzVffLZ1qT1Xc1D8UhTaA7bN75Gj84eu7vbC7YCHUOY-WYWFSx7BwurAp4DiDVitNahiENkhrlBAM9w1LHQvFtILUJDYJIhhteAZDML1Ptqq6sg8JddpplWjIp8HBI5ep0gH04qxwKsociwMS9XqWumMfx0sw5tJnISKXrWkkmEaiaeQ6IK83Xc5a6o1_Cb9F420EkTXbP6gXJ7JzQhlZk0SFsDEzJUtcUqoc_jPmRhVllBgekBdoeom8GBUW3pyoVdPI_ekXOcpAJRi8k4C86oRcDX-gVXeOAfSAVFoDyZ2BJDiuHjb3I0x2E0cjYy6iHAJQmgbk-aYZe2IxXGXrFcoAxi-iNOOXyyQe3AM-KQLyoB20G90kAHlFyuANfDCcB8obtlSzU089zjKAdIIF5E0_8M99-mW2efRf0s_I9c_vx_Lj_uHBY3IjQVfFCh22Q7aWi5V9AhhwWT7t_Pw3yipV9Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+expression+of+a+novel+Kunitz+type+protease+inhibitor+from+the+human+blood+fluke+Schistosoma+mansoni&rft.jtitle=Parasites+%26+vectors&rft.au=Shiwanthi+L.+Ranasinghe&rft.au=Katja+Fischer&rft.au=Geoffrey+N.+Gobert&rft.au=Donald+P.+McManus&rft.date=2015-08-04&rft.pub=BMC&rft.eissn=1756-3305&rft.volume=8&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1186%2Fs13071-015-1022-z&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_0ed2098e14db42f2ba616617da9b02d7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-3305&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-3305&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-3305&client=summon |